Chembridge Corporation

ChemBridge Corporation is a long-established, privately-held US company that operates as a critical supplier and service provider in the early-stage drug discovery ecosystem. Its core business revolves around providing high-quality, structurally diverse chemical libraries (screening compounds and building blocks) and offering contract research services like custom library synthesis and medicinal chemistry. With a vast catalog of over 1.3 million compounds cited in thousands of publications, ChemBridge has positioned itself as a 'gold standard' vendor, enabling hit identification and lead optimization for clients globally through its online platform and distributor network.

Extensive chemical library platform featuring over 1.3 million diverse small molecule screening compounds, over 20,000 synthetic macrocycles, and 14,000+ building blocks, supported by custom library design and synthetic chemistry services. Accessed via the Hit2Lead.com online store.

ChemBridge competes in a crowded market for chemical libraries and discovery services against large players like Enamine, WuXi AppTec (via its LabNetwork), and MilliporeSigma, as well as numerous smaller specialty CROs. Its competitive edge is its 30+ year reputation, massive compound collection cited in thousands of papers, and focus on novel, lead-like design. It differentiates through its macrocycle offerings and integrated custom chemistry services.